Articles tagged with Cellular Regulation
Researchers have identified a unique bacterial transcription mechanism that enables specific recognition of promoters. This discovery has implications for the design of gene regulation tools and may inform synthetic biology engineering.
A research team discovered that alpha-synuclein activates the plasma membrane calcium pump in negatively charged environments, preventing toxic cell buildup. This understanding has profound implications for unraveling early Parkinson's disease processes and potential diagnostic and therapeutic strategies.
A new antibody created by Cold Spring Harbor Laboratory researchers may offer an effective treatment for some breast cancers. The antibody targets the PTPRD enzyme, which is overabundant in certain breast cancers and helps them spread.
Researchers found that quasimodo (qsm) gene helps sync feeding to light/dark cycles, while genes clock (clk) and cycle (cyc) govern eating/fasting cycles. This discovery sheds light on animal behavior and potential treatments for eating disorders.
Researchers discovered a malaria protein, PfAP2-P, that plays a key regulatory role in immune evasion and parasite development. This protein acts as an activator of proteins required for the parasite to exit infected red blood cells and invade new ones.
University of Alberta researchers have identified taurine as a key player in predicting poor clinical outcomes and treating long COVID. A predictive test and proposed supplement trial aim to minimize symptoms and improve patient outcomes.
Researchers from Columbia University have validated GLS2's ability to promote ferroptosis in murine models. This study suggests that targeting GLS2 may be a potential therapeutic strategy against liver diseases, particularly hepatocellular carcinoma.
Lucas Bowman Sutton, a Rensselaer doctoral student, has been awarded the US Department of Energy's Office of Science Graduate Student Research award to conduct research on the circadian clock at Oak Ridge National Laboratory. He will utilize the Spallation Neutron Source to differentiate proteins that regulate timekeeping in living cells.
A team of researchers aims to develop drug therapies by targeting genes that affect metabolism in people with Down syndrome, potentially improving their quality of life. The project will focus on the protein SIM2, which has been linked to breast cancer and metabolic changes in individuals with the condition.
Researchers discovered BMAL1 is significantly upregulated in senescent cells and modulates the senescence program through AP-1. The study highlights a previously unappreciated role of BMAL1 in regulating cellular senescence and circadian clock components.
A new study reveals that RANK protein suppression affects mammary gland functionality differently depending on pregnancy experience. In female mice, RANK suppression led to successful lactation only during the second pregnancy, suggesting a 'rescue action' by basal cells.
Researchers at UW-Madison discovered that FMRP regulates mitochondrial function in human brain cells even before birth, leading to a potential treatment for FXS. The study suggests that FMRP plays a critical role in prenatal development and may be linked to autism spectrum disorder.
A new AI method leverages causal relationships in genome regulation to efficiently identify optimal genetic perturbations for cellular reprogramming. The technique reduces experimental costs by prioritizing the most informative interventions, leading to faster convergence and more effective results.
Researchers discovered that intrinsically disordered regions (IDRs) in proteins play a critical role in chromatin regulation and gene expression. IDRs form droplets called condensates that separate from surrounding fluid, allowing proteins to congregate and carry out cellular activities.
Researchers discovered protein p53's role in regulating sociability, repetitive behavior, and hippocampus-related learning and memory in mice. Lowering p53 levels led to changes in gene expressions related to behavior, while elevated p53 levels were linked to positive learning outcomes.
Jennifer Hurley, Ph.D., is investigating how the 24-hour cycle affects human health and has been granted $2.1 million over five years from the National Institutes of Health. Disruptions to circadian rhythms have been linked to serious medical conditions such as neurological disorders, cardiovascular disease, and cancer.
Researchers uncover clues about how chemicals released by brain cells regulate our attention span, finding that two neurotransmitters work together in a precise sequence to regulate signal transmission. This discovery could lead to new treatments for neurological conditions associated with concentration difficulties.
A Brown University team developed a hydrogel-based delivery system that balances tumor acidity and increases doxorubicin's effectiveness against cancer cells. Initial lab tests show promising results, paving the way for pre-clinical trials.
Despite recent advances in obesity research, governments struggle to curb rising rates, with experts identifying key unanswered questions about the causes of obesity. The intricacies of body weight regulation, energy demand sensing, and environmental factors are still unclear, highlighting the need for continued research.
Researchers at EMBL Grenoble have obtained the first structure of p38α being activated by MKK6, opening up new directions for developing drugs to stop cytokine storms. The inflammatory response is triggered by a series of kinases, and inactivating p38α could prevent inflammation from occurring.
A novel mitochondrial enzyme was identified as key to reproductive aging, increasing oocyte clustering with age and affecting fertility
Researchers have provided new insights into the role of lipid droplet-localized CETN-SPDL1-L in regulating cone cell lipid droplet localization, crucial for light sensitivity. The study discovered centrin proteins and SPDL1-L collaborate to maintain correct lipid droplet placement.
Researchers have found that the protein Musashi-2 plays a crucial role in regulating type 2a muscle fiber mass and metabolism. The study reveals that Msi2 knockout mice exhibit reduced muscle mass, decreased myoglobin and mitochondria levels, and impaired sugar metabolism.
A Kyoto University team reveals the Dumpy protein as the key factor in controlling 3D tissue structures through external cues. This finding challenges traditional understanding of morphogenesis and opens up new avenues for manufacturing controllable 3D tissue folding with coordinated cell behaviors.
A UNIGE team has identified a new mechanism governing microtubule growth, involving two proteins that form a liquid-liquid phase separation at the tip of the microtubule. This discovery opens up unprecedented prospects for developing new treatments that can act at the heart of cells.
Researchers have identified a cluster of neurons in the hypothalamus called GABRA5 that regulates energy expenditure. Astrocytes control this cluster, producing tonic GABA that inhibits it, leading to weight gain.
The study reveals that magnesium transport proteins are essential for plant metabolism and chloroplast functioning, impacting growth and yield. The analysis of three newly identified magnesium release and transporter proteins shows their importance in photosynthesis.
Scientists at UCSF have developed an artificial kidney that can mimic key functions of a real kidney. The bioreactor keeps kidney cells alive for up to seven days and has shown promising results in animal trials. If successful, the device could improve treatment for kidney disease, making it more effective, tolerable, and comfortable.
A team of KAUST researchers has found a critical protein that regulates cell division and proliferation in breast cancer and leukemia. Their work clears the way for the development of targeted drugs by refuting recent challenges to their approach.
Researchers discovered a new mechanism underlying the heat shock response in Escherichia coli. IbpA suppresses σ32 translation, regulating Hsp expression and aiding cell protection under high temperatures. This finding sheds light on bacterial adaptation to harsh environments.
A new study found that high-stress caregivers had higher klotho levels and longer telomeres in specific immune cells, which may provide protection against aging. In contrast, low-stress caregivers showed no significant associations between klotho levels and telomere length.
Research identifies key molecular signatures and pathways contributing to skeletal muscle strength loss in females with estrogen deficiency. The study found parallel patterns of inhibition and activation across various signaling pathways, including AMPK and calcium signaling.
A study published in Science has identified 135 previously unknown genes associated with pigmentation, shedding light on the regulation of melanin production in humans. The research could help protect lighter-skinned individuals from skin cancer and develop new treatments for vitiligo and other pigmentation diseases.
Researchers have identified a novel therapeutic target for pelvic pain in endometriosis by focusing on the IL-1β pathway and its regulation via the JNK signaling pathway. This study suggests that JNK inhibitors may be effective in reducing neuroinflammation and alleviating symptoms of endometriosis-associated pain.
Researchers have discovered a novel pathway that minimizes liver injury during transplantation by activating the protective CEACAM1-S version. This protective characteristic is regulated by HIF-1α and can be enhanced using molecular tools and alternative gene splicing, reducing organ injury and improving post-transplant outcomes.
Researchers found that confined epithelial cells regulate their size and cell cycle separately, suppressing growth but not division length. The team used lab-grown tissue to observe how cells respond to confinement, revealing a new framework for understanding tissue development and growth.
A team of researchers identified a specific subtype of complement-producing macrophages in atherosclerotic lesions that exacerbate plaque necrosis and cardiovascular events. The study suggests a potential therapeutic target to control complement activation within cells, which may also apply to other chronic inflammatory diseases.
Researchers found that CD4+ T cells initiate fat wasting, while CD8+ T cells induce muscle wasting, which surprisingly helps the mice fight infection and survive. The study sheds light on the complex relationship between immune cells and wasting responses.
A study from Konstanz and Baltimore reveals that around 4.2 million animals have been used for hazard assessment under REACH, with many more expected due to a 2022 revision. Animal-free alternative methods are advocated by researchers, who argue that they provide more meaningful results than animal testing.
Researchers discovered a central regulator, DipM, controlling multiple autolysins and promoting cell constriction in Caulobacter crescentus. The study reveals DipM's role in coordinating bacterial cell wall remodeling and division processes.
Researchers found that BUB1 protein regulates EGFR signaling by reducing receptor internalization, which may lead to new therapeutic interventions for EGFR-driven cancers. The study also showed that BUB1 impacts receptor recycling and degradation, affecting signaling amplitude and duration.
A recent study by the Eustermann group at EMBL Heidelberg reveals that DNA packaging into hexasomes impacts the function of enzymes involved in gene regulation. The researchers used cryo-electron microscopy to visualize the molecular processes of how this packaging regulates genome expression and maintenance.
Researchers investigated hepatic hydrogen sulfide production in a mouse model of Hutchinson-Gilford Progeria Syndrome (HGPS) and found reduced H2S levels in RC-fed mice, with partial rescue on high-fat diet. This study suggests that accelerated aging in HGPS may be partially explained by reduced hepatic H2S levels.
A team from the University of Ottawa has developed a comprehensive screening platform and cellular interrogation tool to facilitate novel drug discovery targeting various human diseases. The 'Tango-Trio' platform can identify small molecule modulators for orphan GPCRs, which have significant untapped therapeutic potential.
Researchers investigate MCL-1i-induced Mcl-1 protein accumulation and its implications in B-cell malignancies. The study reveals a complex mechanism contributing to MCL-1 protein stability upon treatment with MCL-1 inhibitors.
Researchers at DTU Health Tech created a multi-levelled scaffold that enables near-perfect bone healing in just eight weeks, without using growth factors or endocrine factors and cells. The scaffold combines essential bone minerals with mechanical properties matching human bone compressive strength.
Researchers discovered a TIR1/AFB-independent auxin signaling mechanism in Klebsormidium nitens, a primitive alga. They identified KnRAV as a key transcription factor that activates auxin-inducible genes and binds to promoter sequences.
The study found that drug-resistant Leishmania parasites have distinct protein production profiles compared to sensitive parasites, suggesting a global reprogramming of protein synthesis. This pre-emptive adaptation enables the parasite to quickly respond to the presence of the drug and survive when it is absent.
A preclinical study has uncovered the role of Y chromosome gene KDM5D in regulating anti-tumor immune responses and promoting metastasis in male patients with KRAS-mutated colorectal cancer. The study reveals that mutant KRAS drives upregulation of KDM5D, leading to reduced cell adhesion and immune recognition by the immune system.
Researchers developed Genome Architecture Mapping (GAM) to study DNA interactions, revealing novel three-dimensional configurations that were invisible to Hi-C. This technique provides a more comprehensive understanding of genome organization and its impact on health and disease.
Researchers found that the amyloid precursor protein (APP) regulates human neurogenesis, which could be linked to Alzheimer's disease. APP promotes a balance between stem cell proliferation and differentiation, suggesting its disruption may cause premature neurogenesis and cellular stress.
Researchers at NYU Abu Dhabi identified microRNAs associated with a weakened immune response and ICU admission. The study provides new insights into how patient genetic makeup affects disease severity and offers potential biomarkers for disease monitoring.
Researchers from Universitat de Barcelona and Universitat Internacional de Catalunya discuss the non-receptor protein tyrosine kinase Src as a good example of an oncogene. Targeting the Src N-terminal regulatory element (SNRE) has potential as oncotargets to inhibit Src activity only in cancer cells.
A new study has determined the atomic-level structure of a zinc-transporter protein, showing how it regulates zinc levels inside cells through a built-in sensor. The protein acts as a dimer, using feedback to control its activity based on zinc levels.
Scientists at University of Virginia Health System discovered a gene that acts as a master controller for immune tolerance, shedding light on how our immune systems are calibrated to prevent MS. The new understanding could lead to better, more targeted treatments.
LSU Health New Orleans researchers found that a combination therapy using Neuroprotectin D1 and Resolvin D1 boosted brain cell survival, growth, and stability. The therapy showed promising results in reducing lesion volume and improving neurological function in acute ischemic stroke models.
Researchers found that MALAT1 inhibition decreased BRAF RNA and protein levels, while increasing correlation with MAPK-associated genes. MALAT1-ASO treatment also reduced melanoma cell growth and tumor size in xenograft models.
Researchers at the University of Gothenburg have developed a method to kill glioblastoma brain tumours by blocking stress in cancer cells. The treatment, which involves inserting a specially developed molecule into cells, shows promising results with no side effects.
Researchers at the Max Planck Institute found that ghrelin activates specialized nerve cells in the amygdala, promoting food consumption and conveying hunger feelings. The study uncovers the physiological processes behind feeding behavior, which may lead to novel therapeutic approaches for eating disorders.
Researchers found that GPR141 enhances cell migration and proliferation in breast cancer by activating the p-mTOR/p53 signaling pathway. Silencing GPR141 restores p53 expression and attenuates tumor growth, suggesting its role in regulating breast cancer progression and metastasis.